USCAP

04/14/2026

Work through WHO 5th edition and ICC with expert faculty, and apply current classification criteria across lymphoid and myeloid neoplasms in practice.

Join your colleagues at USCAP’s Hematopathology Update in Iceland!

Learn more and register:
https://buff.ly/R4DPNLT

03/21/2026

Coming up soon at - The Maude Abbott Lecture featuring Dr. John R. Goldblum, MD!

This year’s lecture reflects on mentorship, professional relationships, and the experiences that shape a career in academic surgical pathology. Don't miss it!

03/21/2026

New to the USCAP Annual Meeting? Our first timers session offers an overview of the meeting and helpful tips for navigating the program and making the most of your time in San Antonio!



https://buff.ly/qudE6ez

03/16/2026

Ready to share your excitement for ?

We’ve put together graphics and banners you can use to let colleagues know you’ll be attending, presenting a poster, or speaking in San Antonio.

Learn more: https://buff.ly/x5Nj7ze

03/13/2026

We’re nearly one week out from and we’re so excited to reconnect with the pathology community.

It’s not too late to join us in San Antonio or register for on-demand access. Don’t miss the learning, the conversations, and the moments that make the USCAP Annual Meeting special 🤠

03/07/2026

Next-generation sequencing of 576 tumors initially diagnosed as lung squamous cell carcinoma resulted in diagnostic reclassification in 3.5% of cases and an overall clinical yield of 11.0%, challenging the historical premise of low yield.

📗 Modern Pathology
⬇️ Learn More

Lung squamous cell carcinoma (LUSC) is the second most common subtype of non-small cell lung carcinoma (NSCLC), typically associated with a poor prognosis. Unlike lung adenocarcinoma (LUAD), the application of next-generation sequencing (NGS) in LUSC has lagged due to the long-standing perception of...

03/05/2026

⏳ Only 17 days until ! What are you most excited for this year?

🔬 New research
🤝 Connecting with colleagues
📚 Learning from experts
🌎 Being part of the global pathology community

03/01/2026

We are beyond excited to welcome Pathologists-in-Training to . To help you get started, we’ve put together a handy guide highlighting sessions and events tailored specifically for residents and fellows. ➡️ https://buff.ly/ze7jK8N

02/28/2026

In a cohort of 287 DLBCL cases, investigators assess a two-step immunohistochemical algorithm to identify dark zone signature biology, offering a potential alternative to GEP or FISH in select settings. Learn more ⬇️

✅ Just Accepted
📗 Modern Pathology

Diffuse large B-cell lymphoma/High-grade B-cell lymphoma with MYC and BCL2 rearrangement (DLBCL/HGBCL-MYC/BCL2) is a distinct disease entity with worse prognosis and is usually diagnosed with identification of MYC and BCL2 rearrangement by fluorescence in situ hybridization (FISH) analysis. Recent p...

02/26/2026

We’re less than a month away from USCAP’s Annual Meeting in San Antonio! The premier event in pathology is almost here, and we’re excited to see our community come together once again.

Will we see you there? 🤠

02/25/2026

Our field advances because experienced pathologists take the time to guide those coming up behind them.

Apply to serve as a mentor in the USCAP Mentoring Academy and invest in the future of our profession.

The USCAP Mentoring Academy connects pathologists through structured mentorship, supporting both mentors and mentees in professional growth, leadership, and career development.

02/12/2026

Applications of HER2 IHC in NSCLC: Practical Education& Case Reviews
Complimentary registration ⬇️ https://buff.ly/ELUPNtc